67
Participants
Start Date
June 13, 2024
Primary Completion Date
April 22, 2025
Study Completion Date
June 30, 2026
DD01
Dual GLP-1 and glucagon receptor agonist
Placebo
Placebo matching DD01
Summit Research Site, Kansas City
Summit Research Site, Monroe
Summit Research Site, West Monroe
Summit Research Site, Bellaire
Summit Research Site, San Antonio
Summit Research Site, San Antonio
Summit Research Site, Corpus Christi
Summit Research Site, Brownsville
Summit Research Site, Edinburg
Summit Research Site, Georgetown
Summit Research Site, Austin
Summit Research Site, Maitland
Lead Sponsor
Neuraly, Inc.
INDUSTRY